相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation
Georgios Schoretsanitis et al.
CLINICAL PHARMACOKINETICS (2021)
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Madeleine S. A. Tan et al.
PSYCHOPHARMACOLOGY (2021)
Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
Kenya A. Costa-Dookhan et al.
SCIENTIFIC REPORTS (2021)
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed
Georgios Schoretsanitis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Comment on: Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation
Satish Suhas et al.
CLINICAL PHARMACOKINETICS (2021)
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders
Robert L. Smith et al.
SCHIZOPHRENIA RESEARCH (2021)
Clozapine-induced agranulocytosis
Aleksandar Mijovic et al.
ANNALS OF HEMATOLOGY (2020)
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits (vol 10, 198, 2020)
Robert Lovsletten Smith et al.
TRANSLATIONAL PSYCHIATRY (2020)
Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective
Sophie E. Legge et al.
PHARMACOGENOMICS (2019)
A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients
Georgios Schoretsanitis et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism
Robert L. Smith et al.
THERAPEUTIC DRUG MONITORING (2019)
Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism
Antonio F. Pardinas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process
David Dickens et al.
MOLECULAR PHARMACEUTICS (2018)
Sodium valproate and clozapine induced neutropenia: A case control study using register data
Steffi Malik et al.
SCHIZOPHRENIA RESEARCH (2018)
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Peng Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Late Onset Agranulocytosis with Clozapine Associated with HLADR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature
Aakanksha Singh et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
John Lally et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2016)
Seizure Associated with Clozapine: Incidence, Etiology, and Management
Andrew M. Williams et al.
CNS DRUGS (2015)
Rare and very rare adverse effects of clozapine
Pasquale De Fazio et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
Jacqueline I. Goldstein et al.
NATURE COMMUNICATIONS (2014)
Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
Yoshiyuki Tsuda et al.
BMJ OPEN (2014)
Inactivation of human myeloperoxidase by hydrogen peroxide
Martina Paumann-Page et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Clinically Significant Drug Interactions with Atypical Antipsychotics
William Klugh Kennedy et al.
CNS DRUGS (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Life expectancy and cardiovascular mortality in persons with schizophrenia
Thomas M. Laursen et al.
CURRENT OPINION IN PSYCHIATRY (2012)
Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted
Liisa Lahdelma et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto et al.
MOLECULAR PSYCHIATRY (2012)
Another view of the history of antipsychotic drug discovery and development
W. T. Carpenter et al.
MOLECULAR PSYCHIATRY (2012)
Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflammed liver
Ahmad Amanzada et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2011)
Clozapine-related EEG changes and seizures: dose and plasma-level relationships
Seema Varma et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2011)
A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine
I. Cormac et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death
E. Laborde
CELL DEATH AND DIFFERENTIATION (2010)
Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis
Sander S. Rensen et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
John McGrath et al.
EPIDEMIOLOGIC REVIEWS (2008)
Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene
Thomas J. Erichsen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Clozapine underutilization and discontinuation in African Americans due to leucopenia
Deanna L. Kelly et al.
SCHIZOPHRENIA BULLETIN (2007)
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine
Tore Haslemo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
Shuguang Ma et al.
JOURNAL OF MASS SPECTROMETRY (2006)
Human white blood cells synthesize morphine: CYP2D6 modulation
W Zhu et al.
JOURNAL OF IMMUNOLOGY (2005)
N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of MI muscarinic receptors
Z Li et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Peroxidases: a role in the metabolism and side effects of drugs
S Tafazoli et al.
DRUG DISCOVERY TODAY (2005)
An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels
CH Ng et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation
A Mori et al.
DRUG METABOLISM AND DISPOSITION (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Therapeutic drug monitoring of psychotropic drugs - TDM Nouveau
F Bengtsson
THERAPEUTIC DRUG MONITORING (2004)
Nonresponse to clozapine and ultrarapid CYP1A2 activity - Clinical data and analysis of CYP1A2 gene
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
MS Faber et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Valproic acid-induced neutropenia
KS Vesta et al.
ANNALS OF PHARMACOTHERAPY (2003)
Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes:: No association with myeloperoxidase and cytochrome P450206
M Dettling et al.
PHARMACOPSYCHIATRY (2000)
Glutathione S-transferase polymorphisms and their biological consequences
JD Hayes et al.
PHARMACOLOGY (2000)